TrialNeuro-oncology2020

A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes.

Melissa Azoulay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.